Our experience of nearly 30 years conducting clinical trials in patients living with a rare diseases has brought us into contact with many different patient organisations. Today we were honoured to be joined by Rick Thomson, CEO of Beacon, a UK-based non-profit organisation that is building a united rare disease community to support patient groups.
Driven by our Learning & Development Team, as part of our Excellence in Execution initiative, Rick spoke to our employees about their work. We also heard directly from a patient who is living with a rare disease.
Such powerful advocates, sharing their stories, reinforces our belief in the power of our daily work.